AxoGen (NASDAQ: AXGN) and Integer Holdings (NASDAQ:ITGR) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitabiliy, risk and valuation.
Volatility & Risk
AxoGen has a beta of 0.27, indicating that its stock price is 73% less volatile than the S&P 500. Comparatively, Integer Holdings has a beta of 1.3, indicating that its stock price is 30% more volatile than the S&P 500.
Valuation and Earnings
This table compares AxoGen and Integer Holdings’ revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | EBITDA | Earnings Per Share | Price/Earnings Ratio | |
| AxoGen | $45.24 million | 12.40 | -$8.23 million | ($0.45) | -37.67 |
| Integer Holdings | $1.40 billion | 1.00 | $270.28 million | N/A | N/A |
Integer Holdings has higher revenue and earnings than AxoGen.
Analyst Ratings
This is a summary of recent recommendations for AxoGen and Integer Holdings, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| AxoGen | 0 | 0 | 5 | 0 | 3.00 |
| Integer Holdings | 0 | 2 | 0 | 0 | 2.00 |
AxoGen currently has a consensus price target of $14.38, indicating a potential downside of 15.19%. Integer Holdings has a consensus price target of $35.00, indicating a potential downside of 21.44%. Given AxoGen’s stronger consensus rating and higher possible upside, equities research analysts clearly believe AxoGen is more favorable than Integer Holdings.
Institutional and Insider Ownership
63.7% of AxoGen shares are owned by institutional investors. 9.3% of AxoGen shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Profitability
This table compares AxoGen and Integer Holdings’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| AxoGen | -32.05% | -155.78% | -31.67% |
| Integer Holdings | N/A | N/A | N/A |
Integer Holdings Company Profile
Greatbatch, Inc. is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise. Greatbatch Medical’s products include medical devices and components for the cardiac, neuromodulation, orthopedics, portable medical, vascular and energy markets. QiG focuses on developing medical device systems for some of healthcare’s challenges and reflects the Company’s strategic evolution of its product offerings in order to raise the growth and profitability profile of the Company. QiG utilizes a diversified portfolio approach with three investment modes: new medical device systems commercialization, collaborative programs with OEM customers and strategic equity positions in emerging healthcare companies.
Receive News & Ratings for AxoGen Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AxoGen Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
